Filing Details
- Accession Number:
- 0001192482-21-000151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-12 16:16:59
- Reporting Period:
- 2021-02-10
- Accepted Time:
- 2021-02-12 16:16:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267565 | Collegium Pharmaceutical Inc | COLL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746251 | Scott Dreyer | C/O Collegium Pharmaceutical, Inc. 100 Technology Center Drive Stoughton MA 02072 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-10 | 1,901 | $25.95 | 94,439 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-10 | 3,283 | $25.95 | 91,156 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-11 | 2,100 | $24.89 | 89,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 5,798 | $25.33 | 83,258 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units.
- Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.66 to $25.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.95, inclusive.
Billionaire Hedge Funds
